Search
Search Results
Found 66 items.
-
Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia
Published: 28 June 2023435PDF: 152 -
Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCoV-19) vaccine: report of two cases
Published: 23 May 20223579PDF: 244 -
Artificial intelligence and machine learning in hemostasis and thrombosis
Published: 31 January 20241760PDF: 338 -
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024341PDF: 114 -
Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern
Published: 22 October 20241094PDF: 145Supplementary: 110 -
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)
Published: 27 June 20231069PDF: 242Supplementary File: 117 -
Allopurinol-induced acquired von Willebrand syndrome
Published: 25 October 20231469PDF: 145 -
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries
Published: 12 October 2023671PDF: 183 -
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review
Published: 24 October 2022452PDF: 160 -
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history
Published: 7 November 20221801PDF: 201 -
Stroke in women: anticoagulation in a complicated puzzle
Published: 26 August 2024934PDF: 248 -
The use of creatine and the development of deep vein thrombosis. A scoping review
Published: 18 November 2024255PDF: 74Supplementary: 52 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024509PDF: 234 -
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study
Published: 12 October 2023212PDF: 102 -
From rare to aware: confronting Lemierre syndrome
Published: 21 October 20241270PDF: 222 -
Is non-alcoholic fatty liver disease a prothrombotic risk factor?
Published: 19 May 2023478PDF: 160 -
Distal deep vein thrombosis: is there a way out of this dark forest?
Published: 4 September 2024431PDF: 134 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024284PDF: 157 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024443PDF: 186 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024457PDF: 171 -
Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study
Published: 1 December 20221284PDF: 256 -
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?
Published: 16 May 2024986PDF: 113 -
Artificial intelligence, platelets and aspirin
Published: 15 March 2024274PDF: 133 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024934PDF: 188 -
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life
Published: 22 April 2024270PDF: 57 -
New perspectives for prevention of the post-thrombotic syndrome
Published: 22 March 20221287PDF: 413 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241258PDF: 212 -
The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist
Published: 21 August 20241145PDF: 312 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024270PDF: 118 -
Welcome to the 12th ICTHIC!
Published: 16 May 20241248PDF: 164 -
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines
Published: 27 January 2023558PDF: 261 -
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice
Published: 23 May 20224549PDF: 234 -
Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know
Published: 13 September 20222114PDF: 222 -
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?
Published: 15 April 20221920PDF: 490 -
Role of platelet autophagy in cardiovascular diseases
Published: 26 August 2024636PDF: 168 -
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy
Published: 21 July 20222812PDF: 280 -
Well begun is half done
Published: 14 December 20221490PDF: 139 -
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study
Published: 27 July 20224127PDF: 334Supplementary Files: 98 -
Antithrombotic therapy in idiopathic infertility
Published: 3 October 20241354PDF: 292 -
What is the gender of thrombosis? A natural model of precision medicine
Published: 3 August 2023402PDF: 143 -
Welcome to AICE and sincere wishes for peace for the new year 2024
Published: 27 December 20231174PDF: 93 -
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry
Published: 23 May 20225086PDF: 415APPENDIX: 97 -
Venous thromboembolism and mortality in patients with hematological malignancies
Published: 16 May 2024311PDF: 123 -
28th SISET National Congress | Rome, 6-9 November 2024
Published: 6 November 2024972PDF: 158 -
The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
Published: 26 April 20221851PDF: 307 -
Oral Communications and Posters
Published: 16 May 2024248PDF: 272 -
The clinical usefulness of measuring thrombin generation
Published: 6 March 2023735PDF: 308 -
Thrombotic thrombocytopenic purpura: much done, but still a lot to do
Published: 29 August 2024410PDF: 138 -
Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond
Published: 3 August 20231013PDF: 233 -
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series
Published: 17 October 20222265PDF: 192 -
The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research
Published: 19 November 2024179PDF: 79 -
Polycythemia vera and management of the thrombotic risk: an update
Published: 20 December 20231717PDF: 225 -
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art
Published: 4 September 2024555PDF: 122SUPPLEMENTARY MATERIAL: 79 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024939PDF: 142 -
Gene transfer in hemophilia A: not cogent yet
Published: 20 April 20221969PDF: 211 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024335PDF: 156 -
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma
Published: 9 March 2023530PDF: 320 -
The new era of anticoagulation: factor XI and XII inhibitors
Published: 7 June 20231813PDF: 782 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024304PDF: 107 -
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Published: 3 August 20231191PDF: 409 -
An ecological alliance against air pollution and cardiovascular disease
Published: 22 March 20221649PDF: 249 -
Growing weapons to fight hemophilia
Published: 23 February 2023638PDF: 273
1 - 66 of 66 items
